IC100, a monoclonal antibody that inhibits ASC oligomerization, has been found to attenuate inflammatory responses in the EAE model and exert considerable therapeutic potential, suggesting potentials of ASC inhibitors for neurodegenerative diseases [194]. This evidence concerns the gene PYCARD and neurodegenerative disease.